Email Us Here

Genelex CEO Kristine Ashcraft to Share Insights on Future of Pharmacogenomics at 8th Annual Personalized & Precision Medicine Conference

Genelex responded to requests by various stakeholders in the personalized and precision medicine industry by creating High Risk PGx Drug Charts, which are available on the YouScript software.